Global Longlife Hospital And Research Ltd vs Healthcare Global Enterprises Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Global Longlife Hospital and Research Ltd is ₹ 12.82 as of 30 Oct 15:30 . The P/E Ratio of Global Longlife Hospital and Research Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Healthcare Global Enterprises Ltd changed from 69.7 on March 2022 to 570.3 on March 2026 . This represents a CAGR of 52.26% over 5 years The Market Cap of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Healthcare Global Enterprises Ltd changed from ₹ 2394 crore on March 2021 to ₹ 7833 crore on March 2026 . This represents a CAGR of 21.84% over 6 years The revenue of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Healthcare Global Enterprises Ltd for the Jun '26 is ₹ 708.16 crore as compare to the Mar '26 revenue of ₹ 665.92 crore. This represent the growth of 6.34% The ebitda of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Healthcare Global Enterprises Ltd for the Jun '26 is ₹ 135.32 crore as compare to the Mar '26 ebitda of ₹ 106.76 crore. This represent the growth of 26.75% The net profit of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Healthcare Global Enterprises Ltd changed from ₹ 13.63 crore to ₹ 16.46 crore over 9 quarters. This represents a CAGR of 8.75% The Dividend Payout of Global Longlife Hospital and Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Healthcare Global Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012.
The Hospital started journey in 2015 & determined to build an institution that offer to every human being, high quality healthcare at affordable prices in Ahmedabad. Mr. Dhruv Jani had also joined the hospital business with his father in July 2015.
The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017.

About Healthcare Global Enterprises Ltd

Healthcare Global Enterprises Limited was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a Private Limited Company.
The name of the Company was changed to HealthCare Global Enterprises Private Limited on November 14, 2005.
Thereafter, it was converted into a Public Limited Company and the name of the Company was changed to Healthcare Global Enterprises Limited on July 5, 2006. Presently, the Company is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.
Under the 'HCG' brand, the Company operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed by the AERB.

FAQs for the comparison of Global Longlife Hospital and Research Ltd and Healthcare Global Enterprises Ltd

Which company has a larger market capitalization, Global Longlife Hospital and Research Ltd or Healthcare Global Enterprises Ltd?

Market cap of Global Longlife Hospital and Research Ltd is 13 Cr while Market cap of Healthcare Global Enterprises Ltd is 8,731 Cr

What are the key factors driving the stock performance of Global Longlife Hospital and Research Ltd and Healthcare Global Enterprises Ltd?

The stock performance of Global Longlife Hospital and Research Ltd and Healthcare Global Enterprises Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Global Longlife Hospital and Research Ltd and Healthcare Global Enterprises Ltd?

As of November 1, 2026, the Global Longlife Hospital and Research Ltd stock price is INR ₹12.82. On the other hand, Healthcare Global Enterprises Ltd stock price is INR ₹584.8.

How do dividend payouts of Global Longlife Hospital and Research Ltd and Healthcare Global Enterprises Ltd compare?

To compare the dividend payouts of Global Longlife Hospital and Research Ltd and Healthcare Global Enterprises Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.